Home/Filings/4/0001213900-21-056740
4//SEC Filing

Lowdell Mark William 4

Accession 0001213900-21-056740

CIK 0001711754other

Filed

Nov 3, 8:00 PM ET

Accepted

Nov 4, 4:00 PM ET

Size

4.7 KB

Accession

0001213900-21-056740

Insider Transaction Report

Form 4
Period: 2021-11-03
Lowdell Mark William
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2021-11-03$20.00/sh701$14,0201,472,793 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

Issuer

Inmune Bio, Inc.

CIK 0001711754

Entity typeother

Related Parties

1
  • filerCIK 0001767037

Filing Metadata

Form type
4
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 4:00 PM ET
Size
4.7 KB